BiondVax

BVXV NASDAQ
6.01
-0.07
-1.15%
已收盘, 16:00 07/17 EDT
开盘
6.15
昨收
6.08
最高
6.15
最低
6.01
成交量
1,591
成交均量(3M)
5,190
52周最高
7.26
52周最低
3.510
换手率
0%
市值
9.17亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供BiondVax BVXV股票价格,BiondVax股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company. The Company holds a worldwide exclusive license granted by Yeda Research and Development Ltd., the commercial arm of the Weizmann Institute, Israel, for developing, manufacturing and commercializing the flu vaccine. BiondVax Pharmaceuticals Ltd develops a biopharmaceutical universal flu vaccine, designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. Its technology utilizes a combination of conserved epitomes from influenza virus proteins to activate the immune system for a cross-protecting and long-lasting effect. The Company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic.
展开 >

最近浏览

名称
价格
涨跌幅